A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Forasartan
Velpatasvir
The serum concentration of Velpatasvir can be increased when it is combined with Idelalisib.
Forasartan
ONT-093
The serum concentration of Idelalisib can be increased when it is combined with ONT-093.
Forasartan
Laniquidar
The serum concentration of Idelalisib can be increased when it is combined with Laniquidar.
Forasartan
Sarecycline
The serum concentration of Idelalisib can be increased when it is combined with Sarecycline.
Forasartan
Pibrentasvir
The serum concentration of Pibrentasvir can be increased when it is combined with Idelalisib.
Forasartan
Elagolix
The serum concentration of Elagolix can be increased when it is combined with Idelalisib.
Forasartan
Valspodar
The serum concentration of Valspodar can be increased when it is combined with Idelalisib.
Forasartan
Fostemsavir
Fostemsavir may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Ripretinib
Ripretinib may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Nabiximols
Nabiximols may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Cannabidiol
Cannabidiol may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Daclatasvir
Daclatasvir may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Paritaprevir
Paritaprevir may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Avatrombopag
Avatrombopag may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Dasabuvir
Dasabuvir may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Forasartan
Adenovirus type 7 vaccine live
The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Idelalisib.
Forasartan
Vibrio cholerae CVD 103-HgR strain live antigen
The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Idelalisib.
Forasartan
Human adenovirus e serotype 4 strain cl-68578 antigen
The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Idelalisib.
Forasartan
BCG vaccine
The risk or severity of infection can be increased when BCG vaccine is combined with Idelalisib.
Forasartan
Bacillus calmette-guerin substrain danish 1331 live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Idelalisib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3